Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Runcuize Biotechnology is a specialized medical technology company focused on the development of high-performance porous tantalum biomaterials for orthopedic and reconstructive surgery. Founded in 2014 and headquartered in Xi'an, China, the company has established a leading position in the porous tantalum sector, producing implants that offer superior biocompatibility and osteoconductive properties compared to traditional titanium. Their commercialized product line includes spinal fusion cages, bone interface materials, and femoral head supports, all designed to facilitate rapid bone ingrowth and long-term stability. Runcuize utilizes proprietary manufacturing processes to create a trabecular metal structure that closely mimics human cancellous bone. The company operates a large-scale manufacturing facility and collaborates extensively with clinical institutions to advance the application of customized metal implants in regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Runcuize Biotechnology.